As expected, we found that there were no significant differences of Shh, Ptch1, Smo, Gli1 mRNA expression when comparing CML-CP patients with IM treated or not(p > 0.05)(see Table 2). This evidence concerns the gene SHH and chronic myelogenous leukemia, BCR-ABL1 positive.